Prof. Kerstin Bartscherer leads the Animal Physiology department at Osnabrück University, focusing on mechanisms of tissue regeneration in organisms such as planarian flatworms and spiny mice (Acomys). Her research emphasizes scar-free regeneration, cardiac repair, and evolutionary insights into regenerative capabilities. She co-leads the EU-funded Regenerate-IT doctoral network and recently organized the successful 25th German Society for Developmental Biology conference. Her team includes PhD students Saman Ghodsi and Robert Kopplin, and collaborates with junior research group leader Dr. Lena Tveriakhina. Key projects explore stem cell regulation, comparative regeneration strategies, and in vitro models using iPSC-derived cells. Education & Affiliations: No explicit educational background provided in texts, but affiliated with Osnabrück University's Biology faculty. Research Interests: Integrates molecular biology, comparative physiology, and evolutionary approaches to identify barriers to regeneration in mammals versus regenerative species. Prioritizes translational applications for human regenerative medicine. Publications highlight groundbreaking work on spiny mouse ear regeneration mechanisms and cardiac repair processes. Current initiatives include cross-disciplinary training via the Regenerate-IT network, fostering the next generation of regeneration biologists. Grants & Projects: EU MSCA-DN Regenerate-IT funding, institutional support for comparative regeneration studies. Labs/Teams: Animal Physiology lab team with specialized focus areas in stem cell dynamics, transcriptomics, and in vivo/in vitro model systems.
Kari Vaahtomeri is a University Researcher at the University of Helsinki, affiliated with the Molecular and Integrative Biosciences Research Program and the CAN-PRO Translational Cancer Medicine Program. He serves as a Cellular Communication Supervisor in the Doctoral Programme in Integrative Life Science, focusing on lymphatic biology, immune cell migration, and tumor-endothelial interactions. Research Programs: Molecular and Integrative Biosciences, CAN-PRO Translational Cancer Medicine Supervision: Doctoral Programme in Integrative Life Science His research explores the lymphatic system's role in cancer metastasis, immune cell transmigration, and vascular network development. Key areas include chemokine signaling, endothelial cell dynamics, and the molecular mechanisms of antigen presentation in tumors. Recent publications highlight his work on lymphatic endothelial multicellular junctions, melanoma-lymphatic crosstalk, and AMPK signaling in lung cancer immune evasion. His projects span from 2017 to 2027, funded by the Sigrid Jusélius Foundation and the Academy of Finland. Key Collaborations: IST Austria, international lymphatic research networks Activities: Oral presentations at conferences, academic visits to research institutions
Marco Tripodi is a researcher at the University of Cambridge's MRC Laboratory of Molecular Biology (LMB), focusing on neural circuits for goal-oriented actions. His work explores how sensory inputs translate into coordinated movements. Research Focus : Neural circuit organization, motor control, sensory-motor integration, and brain mapping. Methodologies : Mouse genetics, optogenetics, viral circuit tracing, in vivo electrophysiology, and behavioral analysis. Recent studies highlight his lab's contributions to understanding collicular circuits, sensorimotor alignment, and advanced tools like self-inactivating rabies for neural circuit mapping. Publications span high-impact journals including Nature, Current Biology, and Cell. His group includes researchers exploring these areas collaboratively. Awards and broader affiliations are not explicitly mentioned in the provided text.
Yuri Pritykin is an Assistant Professor at Princeton University, affiliated with the Lewis-Sigler Institute for Integrative Genomics and the Department of Computer Science. He also holds cross-appointments in Molecular Biology, the Omenn-Darling Bioengineering Institute, and the Center for Statistics and Machine Learning. Pritykin earned his Ph.D. in Computer Science from Princeton University (2014), alongside MSc and Ph.D. in Mathematics from Lomonosov Moscow State University. His research lies at the intersection of applied statistics, machine learning, and functional genomics, focusing on integrative analysis of multi-dimensional biological data. Research Interests: Decoding regulatory genomics in immune cells, CRISPR tool development (GuideScan2), single-cell and spatial multi-omics for immunology and cancer, post-transcriptional regulation, and cell-cell interaction profiling (uLIPSTIC technology). Awards: NSF CAREER Award (2023) NIH New Innovator Award (2022) Recognized by Princeton Ludwig Institute, Rutgers Cancer Institute, and AACR Teaching: Courses in computational biology, genomics, and machine learning applications in life sciences. His lab actively collaborates with immunologists and genomicists, seeking interdisciplinary scientists at all career stages.
Carlijn Bouten is Full Professor of Cell-Matrix Interactions in Cardiovascular Regeneration at Eindhoven University of Technology. She leads the Soft Tissue Engineering & Mechanobiology group, investigating cellular interactions with extracellular environments in tissue growth, adaptation, and regeneration. Her research develops biodegradable heart valve prostheses that enable in vivo tissue regeneration, applying tissue engineering approaches to cardiovascular medicine. Professor Bouten holds an MSc from Vrije Universiteit Amsterdam and a PhD from TU/e. She completed postdoctoral research at Université Laval and University of London before joining TU/e's faculty. She directs the national Gravitation program 'Materials-Driven Regeneration' and received an ERC Advanced Grant for cardiac tissue organization research. Research Focus: Her interdisciplinary program spans: Mechanobiological cues in tissue regeneration Development of living heart valve replacements Advanced biomaterials for cardiovascular applications In vitro models for tissue development Soft robotic systems for cardiac assistance Recent publications demonstrate innovations in biohybrid devices, standardized biomaterial testing, and novel tissue patterning techniques. Her work integrates engineering, materials science, and clinical translation through collaborations with medtech spin-offs. Leadership and Recognition: Fellow of the European Alliance for Medical and Biological Engineering President-elect of the Heart Valve Society Member of AcademiaNet for Outstanding Female Scientists Recipient of NWO VICI grant and Aspasia award She leads multinational consortia in regenerative medicine and teaches courses on heart/blood physiology and regeneration. Her lab develops model systems spanning cellular to tissue levels to quantify mechanobiological processes.
Carolyn Mills is an Assistant Professor in the Department of Bioengineering at the University of California, Santa Barbara, specializing in molecular engineering of proteins for spatial organization in biological systems with applications in plastic remediation and oral vaccine delivery. Education: PhD, Chemical Engineering, Massachusetts Institute of Technology (MIT) BS, Chemical Engineering, UC Santa Barbara Her research integrates protein engineering, synthetic biology, and polymer science to manipulate spatial organization. Key focus areas include bacterial microcompartments for PET waste remediation, liquid-liquid phase separation characterization using cell-free systems, anaerobic platforms for lignin breakdown, and probiotic-based oral vaccine delivery using virus-like particles. The Mills Lab employs high-throughput screening and cell-free protein synthesis to develop closed-loop plastic degradation systems and low-cost vaccine scaffolds. Recent publications (2022-2025) demonstrate consistent innovation in protein self-assembly mechanisms, bacterial organelle engineering, and environmental/medical applications, with strong emphasis on scalable solutions for plastic pollution and global vaccine access. Scientific awards: Distinguished Postdoctoral Service Award, Northwestern University Dr. Mills leads collaborative projects with Prof. Michelle O'Malley and ExFAB (UCSB's NSF Biofoundry), focusing on anaerobic fungal pathways. Her lab bridges fundamental protein dynamics with real-world applications in environmental sustainability and biomedical engineering through engineered spatial organization strategies.
Andrew Godwin is a Professor at the University of Kansas Medical Center , where he serves as the Chancellor’s Distinguished Chair in Biomedical Sciences and Director of Molecular Oncology in the Department of Pathology and Laboratory Medicine. He is also the Deputy Director of the NCI-designated University of Kansas Cancer Center and the Founding Director of the Kansas Institute for Precision Medicine and Biospecimen Shared Resource . Dr. Godwin is a leader in translational research and precision medicine , with a focus on molecular oncology , biomarker discovery , and genomic diagnostics . His work bridges basic and clinical science to improve cancer patient care, particularly in ovarian cancer , Ewing sarcoma , and breast cancer . He has contributed over 230 ovarian cancer-related publications and pioneered studies linking the PI3K/AKT pathway to cancer treatment targets. His research program encompasses liquid biopsies using extracellular vesicles , molecular therapeutics , companion diagnostics , and clinical trial validation . He leads the Biomarker Discovery Laboratory and has secured over $250M in extramural funding , including a $11.4M NIH grant for precision medicine initiatives. His team has developed CELLSEARCH® , the first FDA-cleared test for circulating tumor cells. Notable awards include the Dolph C. Simons, Sr. Higuchi Award (2020), Outstanding Mentorship in Pathology Award (2024), and multiple mentoring accolades from KU. He has mentored over 150 trainees across career stages and leads a multidisciplinary lab with expertise in genomics , proteomics , and bioengineering . Academic Roles: Chancellor’s Distinguished Chair in Biomedical Sciences Director, Molecular Oncology, Pathology and Laboratory Medicine Deputy Director, KU Cancer Center Founding Director, Kansas Institute for Precision Medicine Adjunct Professor, Bioengineering Program, University of Kansas Scientific Awards: KUMC Achievement Award for mentoring postdocs (2014) Chancellor’s Club Award for Research (2018) Dolph C. Simons, Sr. Higuchi Award (2020) KU Excellence in Mentoring Award (2021) Outstanding Mentorship in Pathology (2024) Key Research Themes: Extracellular vesicles as liquid biopsy tools Molecular mechanisms of sarcoma and breast cancer Genomic diagnostics and precision oncology Clinical trial biomarker validation Biospecimen repository leadership
David W. Roberts is an Adjunct Professor of Engineering and holds dual professorships in Surgery (Neurosurgery) and Neurology at the Geisel School of Medicine at Dartmouth College. He specializes in stereotactic and functional neurosurgery, cancer neurosurgery, and intraoperative imaging technologies. His work focuses on advancing image-guidance systems and computational modeling for neurosurgical applications. Education includes an AB from Princeton University (1972), MD from Dartmouth Medical School (1975), and MA from Oxford University (1978). He is actively involved in professional organizations such as the American Academy of Neurological Surgery and serves on editorial boards for journals like Stereotactic and Functional Neurosurgery . His research emphasizes improving glioma resection through fluorescence imaging and real-time surgical guidance. Notable projects include preoperative image updating for tumor resection and quantitative analysis of protoporphyrin IX in gliomas. Recent publications (2011–2012) explore technical advancements in fluorescence-guided surgery and correlations between imaging biomarkers and histopathological malignancy. Roberts has been instrumental in clinical trials evaluating 5-aminolevulinic acid (5-ALA) for glioblastoma treatment and contributed to FDA-approved imaging technologies for surgical guidance. His work bridges engineering innovations with clinical neurosurgical practice, enhancing precision in tumor resection and patient outcomes.
Loic Binan is an Assistant Professor in the Department of Human Genetics at McGill University, with additional affiliations as an Associate Member in the Department of Biomedical Engineering and the Integrated Program in Neuroscience. His research focuses on developing cutting-edge technologies to investigate how gene networks control the self-organization of cells into complex 3D tissues during development and in disease conditions. Dr. Binan's research interests span multiple interdisciplinary fields, with particular emphasis on cancer metastasis , where he investigates the genetic mechanisms allowing cells to reversibly transition between epithelial and mesenchymal phenotypes. His work also explores isoforms and non-coding regions , developing technologies to understand alternative splicing in neurodegenerative diseases, and examining how past cell-cell interactions shape present transcriptional activity during development. His laboratory employs a diverse array of techniques including CRISPR gene editing, spatial transcriptomics, single-cell RNA sequencing, advanced microscopy, and computational methods for image analysis. The recent publications reveal a strong trend toward integrating high-throughput genetic screening with spatial transcriptomics to map gene regulatory networks across both cancer biology and neuroscience contexts. Dr. Binan leads the Binan Lab at the Lady Davis Institute for Medical Research, where his team develops precision gene editing tools such as Cas9 and Cas12 for high-throughput screens, creates novel imaging tools to collect spatial context data, and builds computational tools to analyze these complex new data types. His research primarily focuses on cancer and neurodegenerative diseases, with particular attention to brain development and tumor microenvironments.
Professor Kristopher Kilian is Director of the Laboratory for Advanced Biomaterials & Matrix Engineering (LAB&ME) with a joint position across the School of Chemistry and the School of Materials Science & Engineering in the Faculty of Science at UNSW Sydney. He serves as co-Director of the Australian Centre for NanoMedicine (ACN) and is a member of the Adult Cancer Program in the Prince of Wales Clinical School. His interdisciplinary research focuses on unraveling 'matrix structure-cell function' relationships through innovative biomaterial design. After completing his PhD at the University of New South Wales, Kilian pursued NIH postdoctoral training at the University of Chicago before faculty positions at the University of Illinois at Urbana-Champaign (2011-2018). He returned to UNSW in 2018 as a Scientia Fellow, establishing his current leadership roles. Research Focus: Design of model extracellular matrices and dynamic hydrogels for cell and tissue engineering Fundamental studies in cell plasticity and matrix-directed cell fate Development of synthetic tumor microenvironments for drug testing iPSC-derived organoid bioengineering 4D biofabrication techniques Tissue engineering approaches for lab-grown meat applications His extensive publication record demonstrates consistent focus on hydrogel mechanics, dynamic biomaterials, and the role of physical cues in directing cell behavior. Recent work emphasizes mechanochemistry, spatial control of cell differentiation, and the development of sophisticated tumor models that replicate the complexity of cancer microenvironments. Scientific Recognition: Cornforth Medal (2008) NIH Ruth L. Kirchstein Award (2008) Kavli Fellow (2014) NSF CAREER Award (2015) Australian Research Council Future Fellowship (2018) Eureka Prize finalist (2023) Kilian's research program bridges fundamental cell biology with translational applications, particularly in cancer modeling and regenerative medicine. His laboratory develops innovative biomaterial platforms that enable precise control over cellular microenvironments, facilitating discoveries in cell plasticity and tissue engineering. The group's work on dynamic hydrogels and mechanochemical systems represents a significant contribution to the field of biomaterials science. As Director of LAB&ME, Kilian leads a multidisciplinary team that integrates nano- and micro-fabrication techniques with synthetic chemistry to create biomimetic materials. The laboratory's approach centers on the concept that cell state and fate are governed by inherent cell plasticity within specific multivariate signaling contexts.
Elliot Hui, Ph.D., is an Associate Professor in the Department of Biomedical Engineering at the University of California, Irvine (UCI), within the Samueli School of Engineering. His research focuses on biological microtechnology, including spatial cell biology, microscale tissue engineering, global health diagnostics, and microfluidic computing. He leads the Hui Lab, which develops tools for automating biochemical reactions, controlling cellular organization, and understanding tissue development dynamics. Key achievements include pioneering microfluidic logic systems for autonomous laboratory automation and creating novel cell culture platforms to study intercellular communication in tissues. His work bridges engineering and biology, addressing challenges in diagnostics and regenerative medicine. Notable contributions include the development of a programmable finite state machine for microfluidic control and a SLAS Fellowship awarded to his student Erik. Research Interests: Microfluidic devices, cell-cell interaction modeling, tissue engineering, and lab-on-a-chip systems. Labs/Teams: Hui Lab at UCI, specializing in microscale biological systems and automation. Publications span topics such as microfluidic computing architectures, tissue dissociation devices, and Bayesian experimental design. His work emphasizes applications in global health diagnostics and mechanistic studies of cellular processes.
Lesley W. Chow is an Associate Professor in Bioengineering and Materials Science & Engineering at Lehigh University. She leads the Chow Lab, focusing on designing biomaterials for regenerative medicine and tissue engineering, particularly musculoskeletal interfaces like the osteochondral junction. Her work integrates 3D printing, peptide-polymer conjugates, and self-assembly techniques to create hierarchical scaffolds mimicking native tissues. Chow holds a Ph.D. in Materials Science and Engineering from Northwestern University and a B.S. in Materials Science and Engineering from the University of Florida. Her research emphasizes understanding how tissue organization influences cell behavior and improving clinical translation of biomaterials. Key areas include osteochondral interface regeneration, immunomodulatory biomaterials, and spatially functionalized scaffolds using additive manufacturing. Her lab’s innovations address challenges in musculoskeletal repair, such as creating gradient scaffolds to replicate native tissue properties. Collaborations span biomaterials science, engineering, and clinical translation. She also advocates for diversity in engineering through frameworks promoting institutional accountability. Major grants include the NSF CAREER Award for spatially organized biomaterials. Her work is published in journals across biomaterials science and tissue engineering, with a focus on interdisciplinary solutions for complex tissue regeneration.
George M. Church is a Professor of Genetics at Harvard Medical School and affiliated with MIT, where he directs PersonalGenomes.org, providing open-access genomic, environmental and trait data. His laboratory focuses on transformative technologies for reading and writing 3D/4D biological structures with attention to ethics, safety, and equitable access. Church has co-initiated major scientific initiatives including the BRAIN Initiative (2011) and multiple Genome Projects (GP-Read-1984, GP-Write-2016, PGP-2005). Church's research spans multiple cutting-edge domains including genome engineering, synthetic biology, aging reversal, and space genetics. His lab pioneered foundational methods for direct genome sequencing, molecular multiplexing and barcoding in 1984, leading to the first genome sequence in 1994. His innovations contributed to nearly all next-generation DNA sequencing methods and companies. Current research directions include machine learning for protein engineering, tissue reprogramming, organoids, gene therapy, and in situ 3D DNA/RNA/protein imaging. His work bridges fundamental biology with therapeutic applications across diverse fields from Alzheimer's disease to de-extinction biology. Church's recent publications reveal a remarkable breadth of scientific inquiry, spanning from fundamental genome editing techniques to applications in aging research, neuroscience, and space biology. His work increasingly integrates artificial intelligence with biological systems, as seen in papers on machine-guided cell-fate engineering and automation of systematic reviews with large language models. His research maintains a strong translational focus, with numerous papers addressing therapeutic applications in cancer immunotherapy, gene therapy, and diagnostics. The consistent theme across his diverse publications is the development and application of transformative technologies to address fundamental biological questions and medical challenges. National Academy of Sciences (NAS) membership National Academy of Engineering (NAE) membership Franklin Bower Laureate for Achievement in Science Co-initiator of the BRAIN Initiative (2011) Director of multiple NIH Centers for Excellence in Genomic Science (2004-2020) Church directs numerous research centers including the NIH-CEGS, Personal Genome Project (PGP), Lipper Center for Computational Genetics, and Wyss Institute Synthetic Biology center. His laboratory has trained PhD students across multiple Harvard and MIT programs including Biophysics, BBS, Biomedical Informatics, ChemBio, Chemistry, SSQB, MCO, Virology, HST, EE/CS, Physics and Applied Math. His commercial impact is extensive through companies spanning medical diagnostics (Knome/PierianDx, Alacris, Nebula, Veritas) and synthetic biology/therapeutics (AbVitro/Juno, Gen9/enEvolv/Zymergen/Warpdrive/Gingko, Editas, Egenesis). Church also pioneered new privacy, biosafety, ELSI, environmental and biosecurity policies. The Church Lab operates across multiple research domains including molecular multiplexing, next-generation sequencing, nanopore technology, and genome engineering. The lab maintains strong connections with the Personal Genome Project, Wyss Institute, and multiple commercial ventures. Current research directions include the Spatial Atlas of Human Anatomy (SAHA), human skin rejuvenation via mRNA, and space genetics research through the Consortium for Space Genetics and BioAstra. The lab's mission focuses on transformative technologies for reading and writing 3D/4D structures at any scale, inspired by but not limited by biology.
Richard Kempter is a Full Professor at the Humboldt-Universität zu Berlin, where he leads the Theoretical Neuroscience research group within the Institute for Theoretical Biology, Department of Biology. His research focuses on the neural basis of learning and memory through computational and mathematical modeling of synapses, neurons, and neural networks. He is affiliated with several major research centers including the Bernstein Center for Computational Neuroscience, the Einstein Center for Neurosciences Berlin, and the CRC 1315 Memory Consolidation. Professor Kempter's research interests span theoretical and computational neuroscience with a particular focus on the neural mechanisms underlying learning and memory. His work employs biophysical modeling and mathematical analysis to study synaptic short- and long-term plasticity, the dynamics of single neurons, and the interaction of neurons in recurrently coupled networks. A key aspect of his research investigates how neural systems maintain a balance between learning susceptibility and stability against pathological activity patterns, with model systems including the hippocampus and early auditory system. His research group has made significant contributions to understanding hippocampal sharp wave-ripple events, phase precession in spatial navigation, auditory processing in barn owls, and memory consolidation mechanisms. The group's work combines theoretical approaches with computer simulations to unravel the computational principles of neural circuits, showing particular interest in how neural tissue remains susceptible to learning while maintaining robust stability against pathological activity patterns. Scholarship of the State of Bavaria (03/1994-12/1995) Emmy Noether Fellowship Part I (09/1999-08/2001), funded by the Deutsche Forschungsgemeinschaft Emmy Noether Fellowship Part II (01/2003-09/2008) Guest Professor , HU Berlin, Department of Biology (10/2008-03/2010) Professor Kempter has advised numerous PhD and Master's students throughout his career, with many continuing in neuroscience research. His group maintains strong connections with experimental laboratories to bridge computational models with empirical findings, particularly in hippocampal function and auditory processing. The Theoretical Neuroscience Lab participates in collaborative projects investigating memory consolidation and neural coding principles, contributing significantly to our understanding of how neural circuits implement computational principles underlying learning and memory.
Seraphine V. Wegner is a Full Professor at the Institute of Physiological Chemistry and Pathobiochemistry within the Medical Faculty of the University of Münster. She leads an active research group focused on the spatiotemporal control of cell-material and cell-cell interactions using visible light. Her work bridges synthetic biology, cell biology, and photochemistry to create innovative approaches for tissue engineering and minimal cellular systems. Dr. Wegner's educational background includes a PhD from the University of Chicago (2005-2010) and undergraduate studies at Middle East Technical University in Turkey (2002-2005). Her career path has taken her through prestigious institutions including the Max Planck Institutes in Mainz and Heidelberg, where she established her independent research before joining the University of Münster as a Full Professor in 2019. Her research spans several interconnected areas including light-controlled minimal cellular systems, photoswitchable cell-cell interactions for tissue engineering, light-controlled cell-material interactions, and engineering designer biofilms with light. These research themes share a common thread of using light as a non-invasive tool to precisely control biological processes with high spatial and temporal resolution. Dr. Wegner's publication record shows consistent high-impact output across leading journals in cell biology, synthetic biology, and materials science. Her recent work demonstrates increasing sophistication in multi-color light control systems and applications in both fundamental biological questions and potential therapeutic approaches. ERC Consolidator Grant (2024): LIGHTHOUSE - Light as a signal for nonchemical cell-to-cell communication ERC Starting Grant (2018): ARTIST - Artificial cell-cell interactions for light switchable cell organization and signaling Young Leaders in Science Program, Schering Foundation (2016) MaxSynBio Independent Group Leader, BMBF/MPG (2015) Her research group actively collaborates across disciplines, with projects spanning from fundamental biophysics of cell adhesion to potential medical applications in tissue engineering and bacterial therapeutics. Dr. Wegner has established herself as a leader in the emerging field of optogenetic control of multicellular systems.
